<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2D8E82C0-85D1-4809-90FC-4716F4AF5865"><gtr:id>2D8E82C0-85D1-4809-90FC-4716F4AF5865</gtr:id><gtr:name>Institute of Food Research</gtr:name><gtr:department>Contracts</gtr:department><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:postCode>NR4 7UA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2D8E82C0-85D1-4809-90FC-4716F4AF5865"><gtr:id>2D8E82C0-85D1-4809-90FC-4716F4AF5865</gtr:id><gtr:name>Institute of Food Research</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:postCode>NR4 7UA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DF3C9A5C-3047-42AF-9AFB-804B7140051F"><gtr:id>DF3C9A5C-3047-42AF-9AFB-804B7140051F</gtr:id><gtr:firstName>Francis</gtr:firstName><gtr:surname>Mulholland</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FF%2F00042180"><gtr:id>CE6CC964-F519-49B1-8A7D-C70B52BD161D</gtr:id><gtr:title>IIA Studentship: Selenium and Prostrate Cancer Prevention</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/F/00042180</gtr:grantReference><gtr:abstractText>The hypothesis that will be tested in this studentship is that selenium can modulate levels of various types of collagen to inhibit the reactive stroma effect and prevent prostate cancer growth/progression/invasion. The student will undertake mechanistic studies using cultured prostate cells to investigate effects of different forms and doses of selenium on several key types of collagen in relation to prostate cancer growth, and to study the relationship between collagen formation and breakdown. Confocal microscopy imaging techniques will be used to visualise the types of collagen and study structural changes in collagen and the extracellular matrix, and the relationship between selenium status, key gene/protein expression and tissue phenotype will be investigated.
Project Outline:
Investigate mechanisms of anti-cancer effects of selenium and biomarkers of selenium status in prostate cells/tissue.
Determine effect of dose and form of selenium on global protein expression in prostate cells using proteomics techniques.
Optimise methods (protein extraction and electrophoresis conditions?) to include analysis of extracellular matrix proteins?
Comparison between effects of Selenomethionine and Se-methylselenocysteine and effects of multiple forms combined
Use of human prostate cells normal/cancer model
Identify Selenium-responsive proteins using MALDI-TOF or other suitable mass spec identification techniques, and confirm change using western blotting/enzyme activity and /or ELISA approach
Explore possibility of using prostate tissue explants and 3D cell culture model to identify mechanistic effects of selenium on prostate tissue - proteomics approach?
Investigate the effects of different forms and doses on selenium on the plasma proteome using human samples from selenium dietary intervention study - (identify Se-responsive proteins and mechanisms of effect)
Study cellular effects of selenium on collagen production and extracellular matrix using confocal microscopy techniques</gtr:abstractText><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>51600</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The aim within the IFR laboratory was to determine the influence of Selenium compounds on the proteins expressed by several Prostate Cancer Cell lines. The data showed that the cell lines required different levels of selenium to invoke a response that showed significant changes. The requirement for different amounts of selenium made comparisons between the cell lines problematic and no consistent biomarkers were determined. This work was published in Frontiers in Oncology in 2013 (see web link below).
A 2D-gel approach was employed in this study which is limited by the need to identify each spot on the gel. This restricts full identification of the proteome and lacks information on important membrane associated proteins. Some initial data using a SILAC based approach suggested this MS-based technique would be more applicable for this study. As part of this project preliminary studies were carried to establish conditions for growing the cell line in suitable SILAC media and their subsequent MS-based analysis.</gtr:description><gtr:exploitationPathways>If future studies were to be performed a more comprehensive proteome method such as the SILAC would need to be employed.</gtr:exploitationPathways><gtr:id>9398037E-2E77-4124-BBC1-199A1A658D60</gtr:id><gtr:outcomeId>54635064768327.27529481</gtr:outcomeId><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779855/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>54E92455-4123-48AA-8B90-EEC9F7578351</gtr:id><gtr:title>Selenium Biomarkers in Prostate Cancer Cell Lines and Influence of Selenium on Invasive Potential of PC3 Cells.</gtr:title><gtr:parentPublicationTitle>Frontiers in oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a35b3e35f62e00b2b1bf861b9ff66ea2"><gtr:id>a35b3e35f62e00b2b1bf861b9ff66ea2</gtr:id><gtr:otherNames>Hendrickx W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2234-943X</gtr:issn><gtr:outcomeId>5463644d4c7c65.26470682</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/F/00042180</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>